DMAA
Drugs Made In America Acquisition Corp.Company with tickers: DMAA, DMAAR, DMAAU
CIK
2028614
CUSIP
G2847J104
Shares Outstanding
24,276,913
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-143,301 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $1,970,459 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |